www.fdanews.com/articles/131208-inspiration-rsquo-s-obi-1-receives-orphan-drug-designation-in-europe

Inspiration’s OBI-1 Receives Orphan Drug Designation in Europe

October 19, 2010

Inspiration Biopharmaceuticals, Inc. announced Tuesday that the European Commission has granted orphan drug status for OBI-1 for the treatment of hemophilia.
SunHerald